172 related articles for article (PubMed ID: 29998975)
1. Histological evaluation of myeloproliferative neoplasms.
Fujiwara H
J Clin Exp Hematop; 2018; 58(2):45-50. PubMed ID: 29998975
[TBL] [Abstract][Full Text] [Related]
2. [Histological diagnosis of Ph-negative myeloproliferative neoplasia. An overview].
Campr V
Cesk Patol; 2011 Jul; 47(3):84-93. PubMed ID: 21887923
[TBL] [Abstract][Full Text] [Related]
3. [Utility of bone marrow biopsy in the diagnosis of myeloproliferative neoplasm].
Tovar-Bobadilla JL; Ortiz-Hidalgo C
Gac Med Mex; 2016; 152(3):407-18. PubMed ID: 27335198
[TBL] [Abstract][Full Text] [Related]
4. Acute megakaryocytic myelofibrosis. Case report of an unusual myeloproliferative syndrome.
Estevez JM; Urueta EE; Moran TJ
Am J Clin Pathol; 1974 Jul; 62(1):52-9. PubMed ID: 4833737
[No Abstract] [Full Text] [Related]
5. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
6. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
[TBL] [Abstract][Full Text] [Related]
7. Elliptic Fourier analysis of megakaryocyte nuclei in chronic myeloproliferative disorders.
Nafe R; Kaloutsi V; Choritz H; Georgii A
Anal Quant Cytol Histol; 1992 Oct; 14(5):391-7. PubMed ID: 1299229
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia.
Muth M; Engelhardt BM; Kröger N; Hussein K; Schlué J; Büsche G; Kreipe HH; Bock O
Ann Hematol; 2011 Jan; 90(1):33-40. PubMed ID: 20625903
[TBL] [Abstract][Full Text] [Related]
9. [Acute myelofibrosis: apropos of a case with immunocytochemical and ultrastructural studies].
Ocaña I; Alegre J; Fernández de Sevilla T; Ruiz Marcellán L; Ribera E; Martínez Vázquez JM
Med Clin (Barc); 1989 Jan; 92(3):102-3. PubMed ID: 2496279
[TBL] [Abstract][Full Text] [Related]
10. S100 expression by atypical megakaryocytes: a previously unreported potential pitfall in dermatopathology.
Fernandez-Flores A; Díaz-Galvez FJ
J Cutan Pathol; 2014 Dec; 41(12):963-8. PubMed ID: 25371084
[TBL] [Abstract][Full Text] [Related]
11. Mixed myelodysplastic syndrome and myeloproliferative disorder with bone marrow and pulmonary fibrosis: the role of megakaryocytes.
Rosenstingl S; Brouland JP; Zini JM; Tobelem G; Dupuy E
Acta Haematol; 2003; 109(3):145-9. PubMed ID: 12714825
[TBL] [Abstract][Full Text] [Related]
12. Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic Mutations.
Guo BB; Allcock RJ; Mirzai B; Malherbe JA; Choudry FA; Frontini M; Chuah H; Liang J; Kavanagh SE; Howman R; Ouwehand WH; Fuller KA; Erber WN
Am J Pathol; 2017 Jul; 187(7):1512-1522. PubMed ID: 28502479
[TBL] [Abstract][Full Text] [Related]
13. Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis.
Brousseau M; Parot-Schinkel E; Moles MP; Boyer F; Hunault M; Rousselet MC
Histopathology; 2010 May; 56(6):758-67. PubMed ID: 20546341
[TBL] [Abstract][Full Text] [Related]
14. [Regressive bone marrow changes in leukoses with special reference to their demarcation from myelofibrosis and osteomyelosclerosis].
Martin H
Zentralbl Allg Pathol; 1969; 112(3):310-20. PubMed ID: 4900564
[No Abstract] [Full Text] [Related]
15. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
Macavei I; Galatâr N
Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
[TBL] [Abstract][Full Text] [Related]
17. Cooperation between pathologists and clinicians allows a better diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms.
Gianelli U; Iurlo A; Cattaneo D; Lambertenghi-Deliliers G
Expert Rev Hematol; 2014 Apr; 7(2):255-64. PubMed ID: 24524231
[TBL] [Abstract][Full Text] [Related]
18. [Quantitative study of the medullar fibrosis in 84 cases of idiopathic myeloid splenomegaly (author's transl)].
Dumont J; d'Athis P; Atken N; Binet JL; Ripault J; Worhauer W; Bernard J
Pathol Biol (Paris); 1979 Apr; 27(4):221-6. PubMed ID: 379761
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components.
Castro-Malaspina H
Prog Clin Biol Res; 1984; 154():427-54. PubMed ID: 6089232
[TBL] [Abstract][Full Text] [Related]
20. [Idiopathic myelofibrosis associated with an IgM-secreting immunocytoma].
Dini D; Artusi T; Di Prisco U
Recenti Prog Med; 1991 Feb; 82(2):77-9. PubMed ID: 2034872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
